227 related articles for article (PubMed ID: 15940895)
21. Peer review of validation studies: an assessment of the role of the OECD by reference to the validation of the uterotrophic assay for endocrine disruptors.
Combes RD
Altern Lab Anim; 2004 Jun; 32(2):111-7. PubMed ID: 15601239
[TBL] [Abstract][Full Text] [Related]
22. Validation successes: chemicals.
Spielmann H; Liebsch M
Altern Lab Anim; 2002 Dec; 30 Suppl 2():33-40. PubMed ID: 12513649
[TBL] [Abstract][Full Text] [Related]
23. ECVAM-ICCVAM: prospects for future collaboration.
Schechtman LM; Stokes WS
Altern Lab Anim; 2002 Dec; 30 Suppl 2():227-36. PubMed ID: 12513682
[TBL] [Abstract][Full Text] [Related]
24. ECVAM and the Promotion of International Co-operation in the Development, Validation and Acceptance of Replacement Alternative Test Methods.
Balls M
ALTEX; 1999; 16(4):280-282. PubMed ID: 11107329
[TBL] [Abstract][Full Text] [Related]
25. Currently available in vitro methods used in the regulatory toxicology.
Liebsch M; Spielmann H
Toxicol Lett; 2002 Feb; 127(1-3):127-34. PubMed ID: 12052650
[TBL] [Abstract][Full Text] [Related]
26. Validating new toxicology tests for regulatory acceptance.
Zeiger E; Stokes WS
Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):32-7. PubMed ID: 9629594
[TBL] [Abstract][Full Text] [Related]
27. Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte maturation (IVM) test within ReProTect.
Luciano AM; Franciosi F; Lodde V; Corbani D; Lazzari G; Crotti G; Galli C; Pellizzer C; Bremer S; Weimer M; Modina SC
Reprod Toxicol; 2010 Aug; 30(1):81-8. PubMed ID: 20156549
[TBL] [Abstract][Full Text] [Related]
28. JaCVAM-organized international validation study of the in vivo rodent alkaline comet assay for detection of genotoxic carcinogens: II. Summary of definitive validation study results.
Uno Y; Kojima H; Omori T; Corvi R; Honma M; Schechtman LM; Tice RR; Beevers C; De Boeck M; Burlinson B; Hobbs CA; Kitamoto S; Kraynak AR; McNamee J; Nakagawa Y; Pant K; Plappert-Helbig U; Priestley C; Takasawa H; Wada K; Wirnitzer U; Asano N; Escobar PA; Lovell D; Morita T; Nakajima M; Ohno Y; Hayashi M
Mutat Res Genet Toxicol Environ Mutagen; 2015 Jul; 786-788():45-76. PubMed ID: 26212295
[TBL] [Abstract][Full Text] [Related]
29. The need for a formal invalidation process for animal and non-animal tests.
Balls M; Combes R
Altern Lab Anim; 2005 Jun; 33(3):299-308. PubMed ID: 16180982
[TBL] [Abstract][Full Text] [Related]
30. Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use.
Corvi R; Ahr HJ; Albertini S; Blakey DH; Clerici L; Coecke S; Douglas GR; Gribaldo L; Groten JP; Haase B; Hamernik K; Hartung T; Inoue T; Indans I; Maurici D; Orphanides G; Rembges D; Sansone SA; Snape JR; Toda E; Tong W; van Delft JH; Weis B; Schechtman LM
Environ Health Perspect; 2006 Mar; 114(3):420-9. PubMed ID: 16507466
[TBL] [Abstract][Full Text] [Related]
31. Alternative tests make the grade.
Booker S
Environ Health Perspect; 2000 Mar; 108(3):A118-9. PubMed ID: 10706538
[TBL] [Abstract][Full Text] [Related]
32. Ensuring quality of in vitro alternative test methods: issues and answers.
Gupta K; Rispin A; Stitzel K; Coecke S; Harbell J
Regul Toxicol Pharmacol; 2005 Dec; 43(3):219-24. PubMed ID: 16099570
[TBL] [Abstract][Full Text] [Related]
33. Validation is a key theme in this issue of ALTEX.
von Aulock S
ALTEX; 2011; 28(1):1. PubMed ID: 21404727
[No Abstract] [Full Text] [Related]
34. OECD validation of the Hershberger assay in Japan: Phase 3. Blind study using coded chemicals.
Yamasaki K; Ohta R; Okuda H
Toxicol Lett; 2006 May; 163(2):121-9. PubMed ID: 16289407
[TBL] [Abstract][Full Text] [Related]
35. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D;
Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053
[TBL] [Abstract][Full Text] [Related]
36. International prevalidation studies of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility.
Aardema MJ; Barnett BC; Khambatta Z; Reisinger K; Ouedraogo-Arras G; Faquet B; Ginestet AC; Mun GC; Dahl EL; Hewitt NJ; Corvi R; Curren RD
Mutat Res; 2010 Aug; 701(2):123-31. PubMed ID: 20621637
[TBL] [Abstract][Full Text] [Related]
37. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
38. Practical Aspects of Designing and Conducting Validation Studies Involving Multi-study Trials.
Coecke S; Bernasconi C; Bowe G; Bostroem AC; Burton J; Cole T; Fortaner S; Gouliarmou V; Gray A; Griesinger C; Louhimies S; Gyves EM; Joossens E; Prinz MJ; Milcamps A; Parissis N; Wilk-Zasadna I; Barroso J; Desprez B; Langezaal I; Liska R; Morath S; Reina V; Zorzoli C; Zuang V
Adv Exp Med Biol; 2016; 856():133-163. PubMed ID: 27671721
[TBL] [Abstract][Full Text] [Related]
39. Future improvements: replacement in vitro methods.
Balls M
ILAR J; 2002; 43 Suppl():S69-73. PubMed ID: 12388855
[TBL] [Abstract][Full Text] [Related]
40. Validation and regulatory acceptance of alternatives.
Hill RN; Stokes WS
Camb Q Healthc Ethics; 1999; 8(1):73-9. PubMed ID: 9924621
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
